Newman Michael James 4
4 · Indaptus Therapeutics, Inc. · Filed Aug 6, 2021
Insider Transaction Report
Form 4
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-08-04+290,000→ 290,000 totalExercise: $8.87Exp: 2031-08-04→ Common Stock (290,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.